BIRMINGHAM, AL (WSFA) - Due to the increased cost of EpiPens, Blue Cross and Blue Shield of Alabama will now cover an authorized generic version of EpiPen and EpiPen Jr. at a lower cost.
BCBS says it will no longer cover the EpiPen, EpiPen Jr., and Adrenaclick (including its authorized generic) on most drug lists, beginning July 1 because of a new cost- effective generic alternative. The cost of the medications has increased drastically since 2011. EpiPen prices have increased 270 percent while Adrenaclick prices increased to 180 percent, according to a release from BCBS.
BCBS says the generic alternatives will only impact 9,900 members. Letters have been mailed to all affected members.
Prime Therapeutics, a pharmacy benefit manager, and BCBS say they are committed to obtaining the best medications for the best price for BCBS members.
Concerning BCBS members are encouraged to contact their pharmacist and/or prescribing physician to discuss their treatment options.For any questions regarding this matter, members can call the number on the back of their member ID card or visit the website.